These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5018523)

  • 1. A strategy for the study of behavioral mechanisms of antipsychotic drug action in schizophrenia.
    Spohn HE
    Psychopharmacologia; 1972; 24(1):201-8. PubMed ID: 5018523
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptics improve sustained attention in schizophrenia. A study using signal detection theory.
    Nestor PG; Faux SF; McCarley RW; Sands SF; Horvath TB; Peterson A
    Neuropsychopharmacology; 1991 Feb; 4(2):145-9. PubMed ID: 1673845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of a simple test of attention as a measure of drug effects in schizophrenic patients.
    Kornetsky C
    Psychopharmacologia; 1972; 24(1):99-106. PubMed ID: 4622973
    [No Abstract]   [Full Text] [Related]  

  • 4. Performance tests in a study of phenothiazines in schizophrenia: caveats and conclusions.
    Schooler NR; Goldberg SC
    Psychopharmacologia; 1972; 24(1):81-98. PubMed ID: 5062969
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenothiazine effects in good premorbid schizophrenics divided into paranoid-nonparanoid status.
    Judd LL; Goldstein MJ; Rodnick EH; Jackson NL
    Arch Gen Psychiatry; 1973 Aug; 29(2):207-21. PubMed ID: 4582360
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of daily administration of carphenazine on attention in the schizophrenic patient.
    Orzack MH; Kornetsky C; Freeman H
    Psychopharmacologia; 1967; 11(1):31-8. PubMed ID: 4876301
    [No Abstract]   [Full Text] [Related]  

  • 7. Advantages and problems in the use of performance tests to study schizophrenic deficit.
    Goldberg SC
    Psychopharmacologia; 1972; 24(1):1-5. PubMed ID: 5018522
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective effects of antipsychotic medications on eye-tracking performance in schizophrenia.
    Sweeney JA; Haas GL; Li S; Weiden PJ
    Psychiatry Res; 1994 Nov; 54(2):185-98. PubMed ID: 7761552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.
    Goldberg SC; Frosch WA; Drossman AK; Schooler NR; Johnson GF
    Arch Gen Psychiatry; 1972 Apr; 26(4):367-73. PubMed ID: 4552130
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug effects on auditory attention in paranoid and nonparanoid schizophrenics.
    Rappaport M; Hopkins HK
    J Nerv Ment Dis; 1969 Jun; 148(6):597-605. PubMed ID: 5772724
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia].
    Matkowski K; Sep-Kowalikowa B
    Psychiatr Pol; 1979; 13(4):421-3. PubMed ID: 42095
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary experience in the treatment of schizophrenia with pipothiazine and its derivatives.
    Faltus F; Marecek P; Soucek K
    Act Nerv Super (Praha); 1975 Sep; 17(3):204. PubMed ID: 883
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Psychological' constructs and 'psychological' symptoms in schizophrenia.
    McPherson FM
    Br J Psychiatry; 1972 Feb; 120(555):197-8. PubMed ID: 5043724
    [No Abstract]   [Full Text] [Related]  

  • 15. The stability and sensitivity of measures of thought, perception and emotional arousal.
    Goldstein MJ; Rodnick EH; Jackson NP; Evans JR; Bates JE; Judd LL
    Psychopharmacologia; 1972; 24(1):107-20. PubMed ID: 5018518
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)].
    Masiak M; Majczak A; Hascewicz-Rzecka M; Kowalczyk A
    Psychiatr Pol; 1976; 10(6):655-60. PubMed ID: 13443
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of phenothiazines on anxiety and cognition in schizophrenia.
    Meadow A; Donlon PT; Blacker KH
    Dis Nerv Syst; 1975 Apr; 36(4):203-8. PubMed ID: 234827
    [No Abstract]   [Full Text] [Related]  

  • 18. Work study in the assessment of the effects of phenothiazines in schizophrenia.
    Chacon C; Harper P; Harvey GF
    Compr Psychiatry; 1972; 13(6):549-54. PubMed ID: 4404679
    [No Abstract]   [Full Text] [Related]  

  • 19. Schizophrenia--an unsolved problem.
    Chiu E
    P N G Med J; 1981 Dec; 24(4):217-8. PubMed ID: 6951345
    [No Abstract]   [Full Text] [Related]  

  • 20. Apathy and the processing of novelty in schizophrenia.
    Roth RM; Koven NS; Pendergrass JC; Flashman LA; McAllister TW; Saykin AJ
    Schizophr Res; 2008 Jan; 98(1-3):232-8. PubMed ID: 17884352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.